Related Experiment Video
Updated: Apr 27, 2026
10:03
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
11.4K
Neuropathologic changes of multiple system atrophy and diffuse Lewy body disease
Etty Paola Cortes Ramirez1, Jean Paul G Vonsattel1
1Department of Pathology and Cell Biology, Columbia University Medical Center and the New York Presbyterian Hospital, New York, New York.
Seminars in Neurology
|June 26, 2014
Summary
Multiple system atrophy (MSA) and diffuse Lewy body disease (DLBD) share α-synuclein pathology but affect different cell types and brain regions. Understanding these distinctions is key for diagnosing and potentially treating these neurodegenerative disorders.
Area of Science:
- Neuroscience
- Neuropathology
- Cell Biology
Background:
- Fibrillar α-synuclein accumulation is a key pathology in multiple system atrophy (MSA) and diffuse Lewy body disease (DLBD).
- MSA primarily affects oligodendrocytes, while DLBD targets neuronal subtypes, leading to distinct clinical presentations.
- Both diseases exhibit widespread central nervous system changes with specific regional vulnerabilities.
Purpose of the Study:
- To differentiate the pathological hallmarks and affected cell types in MSA and DLBD.
- To elucidate the distinct topistic vulnerabilities within the central nervous system for each disease.
- To clarify the relationship between MSA subtypes (MSA-C, MSA-P) and DLBD, including its potential as an advanced stage of Parkinson disease.
Main Methods:
- Comparative analysis of neuropathological features in MSA and DLBD.
- Review of diagnostic subtypes and clinical manifestations of MSA (MSA-C, MSA-P) and DLBD (limbic, cortical).
- Examination of anatomical vulnerability and cellular targets in affected brain regions.
Main Results:
- MSA-C shows vulnerability in the brainstem and cerebellum, while MSA-P affects the striatum and mesencephalon, often presenting with parkinsonism.
- DLBD involves Lewy-body-containing neurons in the cerebral cortex, leading to dementia and parkinsonism, potentially representing an advanced stage of Parkinson disease.
- Despite shared α-synuclein pathology, distinct cellular and regional patterns differentiate MSA and DLBD.
Conclusions:
- Multiple system atrophy and diffuse Lewy body disease are distinct neurodegenerative conditions characterized by α-synuclein aggregation but differing in cellular and regional pathology.
- Understanding the specific vulnerabilities and affected cell types is crucial for accurate diagnosis and future therapeutic strategies.
- The precise epidemiological and genetic factors underlying sporadic MSA and DLBD remain unknown and warrant further investigation.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
32
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
32
01:24Parkinson Disease ll: Pathophysiology
22
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
22
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:19Multiple Sclerosis l: Introduction
17
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
17
01:11Alterations in Muscle Tone lll
25
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
25
01:37Neural Regulation
34.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.6K